Sri Aithal pursued his Post-Doc at McMaster University and Ph.D. at Sherbrooke University in Canada.

He drove the effort to commercialize impedance spectroscopy-based sensing at Abnova, Taiwan.

He was also a Co-Founder of Celerite Labs, a startup company commercializing magnetic bio-printing technology that accelerated drug discovery.

Sri has several journal publications and an approved patent.